Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $621.9000 (-1.39%) ($621.9000 - $621.9000) on Tue. Aug. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.01% (three month average) | RSI | 62 | Latest Price | $621.9000(-1.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.5% a day on average for past five trading days. | Weekly Trend | REGN advances 2.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) DIA(37%) IWD(34%) SPLV(33%) SPY(33%) | Factors Impacting REGN price | REGN will decline at least -1.005% in a week (0% probabilities). TBT(-11%) VIXM(-9%) UUP(-5%) VXX(-1%) USO(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.005% (StdDev 2.01%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $617.74(0.67%) | 10 Day Moving Average | $600.31(3.6%) | 20 Day Moving Average | $596.72(4.22%) | To recent high | -10.2% | To recent low | 13.6% | Market Cap | $65.939b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |